OtherArticle
Endogenous plasma kynurenic acid in human: a newly discovered biomarker for drug-drug interactions involving in OAT1 and OAT3 inhibition
Jennifer Tang, Hong Shen, Xiaofeng Zhao, Vinay K. Holenarsipur, T. Thanga Mariappan, Yueping Zhang, Erika Panfen, Jim Zheng, W. Griffith Humphreys and Yurong Lai
Drug Metabolism and Disposition October 1, 2021, DMD-AR-2021-000486; DOI: https://doi.org/10.1124/dmd.121.000486
Jennifer Tang
1Gilead Sciences Inc, United States
Hong Shen
2Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, United States
Xiaofeng Zhao
1Gilead Sciences Inc, United States
Vinay K. Holenarsipur
3Biocon Bristol Myers Squibb R&D Centre (BBRC), India
T. Thanga Mariappan
3Biocon Bristol Myers Squibb R&D Centre (BBRC), India
Yueping Zhang
4Bristol-Myers Squibb, United States
Erika Panfen
5Bristol-Myers Squibb Company, United States
Jim Zheng
6Gilead Science Inc, United States
W. Griffith Humphreys
7PCO, Aranmore Pharma Consultancy, United States
Yurong Lai
8Drug Metabolism, Gilead Sciences Inc., United States
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Kynurenic acid as a biomarker of OAT1/3 inhibition
Jennifer Tang, Hong Shen, Xiaofeng Zhao, Vinay K. Holenarsipur, T. Thanga Mariappan, Yueping Zhang, Erika Panfen, Jim Zheng, W. Griffith Humphreys and Yurong Lai
Drug Metabolism and Disposition October 1, 2021, DMD-AR-2021-000486; DOI: https://doi.org/10.1124/dmd.121.000486
OtherArticle
Kynurenic acid as a biomarker of OAT1/3 inhibition
Jennifer Tang, Hong Shen, Xiaofeng Zhao, Vinay K. Holenarsipur, T. Thanga Mariappan, Yueping Zhang, Erika Panfen, Jim Zheng, W. Griffith Humphreys and Yurong Lai
Drug Metabolism and Disposition October 1, 2021, DMD-AR-2021-000486; DOI: https://doi.org/10.1124/dmd.121.000486
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement